BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28520087)

  • 1. Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry.
    Abtan J; Bhatt DL; Elbez Y; Sorbets E; Eagle K; Reid CM; Baumgartner I; Wu D; Hanson ME; Hannachi H; Singhal PK; Steg PG; Ducrocq G;
    Clin Cardiol; 2017 Sep; 40(9):710-718. PubMed ID: 28520087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH Registry.
    Abtan J; Bhatt DL; Elbez Y; Sorbets E; Eagle K; Ikeda Y; Wu D; Hanson ME; Hannachi H; Singhal PK; Steg PG; Ducrocq G;
    Clin Cardiol; 2016 Nov; 39(11):670-677. PubMed ID: 27588731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry.
    Stavroulakis K; Borowski M; Torsello G; Bisdas T;
    J Vasc Surg; 2017 Nov; 66(5):1534-1542. PubMed ID: 28807382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50).
    Bonaca MP; Gutierrez JA; Creager MA; Scirica BM; Olin J; Murphy SA; Braunwald E; Morrow DA
    Circulation; 2016 Mar; 133(10):997-1005. PubMed ID: 26826179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes.
    Abola MT; Bhatt DL; Duval S; Cacoub PP; Baumgartner I; Keo H; Creager MA; Brennan DM; Steg PG; Hirsch AT;
    Atherosclerosis; 2012 Apr; 221(2):527-35. PubMed ID: 22321872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Year Outcomes of the OLIVE Registry, a Prospective Multicenter Study of Patients With Critical Limb Ischemia: A Prospective, Multi-Center, Three-Year Follow-Up Study on Endovascular Treatment for Infra-Inguinal Vessel in Patients With Critical Limb Ischemia.
    Iida O; Nakamura M; Yamauchi Y; Fukunaga M; Yokoi Y; Yokoi H; Soga Y; Zen K; Suematsu N; Inoue N; Suzuki K; Hirano K; Shintani Y; Miyashita Y; Urasawa K; Kitano I; Tsuchiya T; Kawamoto K; Yamaoka T; Uesugi M; Shinke T; Oba Y; Ohura N; Uematsu M; Takahara M; Hamasaki T; Nanto S;
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1493-1502. PubMed ID: 26404203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Cholinesterase Levels Are Associated With 2-Year Ischemic Outcomes After Angioplasty and Stenting for Peripheral Artery Disease.
    Gremmel T; Wadowski PP; Mueller M; Kopp CW; Koppensteiner R; Panzer S
    J Endovasc Ther; 2016 Oct; 23(5):738-43. PubMed ID: 27328913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
    Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Risk Factors for Limb-Specific Peripheral Vascular Events in Patients With Peripheral Artery Disease: A Post Hoc Analysis of the SEASON Prospective Observational Study.
    Miyata T; Higashi Y; Shigematsu H; Origasa H; Fujita M; Matsuo H; Naritomi H; Matsuda H; Nakajima M; Yuki S; Awano H
    Angiology; 2019 Jul; 70(6):506-514. PubMed ID: 30477334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival.
    Suckow BD; Kraiss LW; Schanzer A; Stone DH; Kalish J; DeMartino RR; Cronenwett JL; Goodney PP;
    J Vasc Surg; 2015 Jan; 61(1):126-33. PubMed ID: 25037607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.
    Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
    Ann Vasc Surg; 2022 Jan; 78():310-320. PubMed ID: 34537348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction.
    Klingelhoefer E; Bergert H; Kersting S; Ludwig S; Weiss N; Schönleben F; Grützmann R; Gäbel G
    J Vasc Surg; 2016 Aug; 64(2):380-388.e1. PubMed ID: 27763266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes in diabetic patients with chronic limb-threatening ischemia.
    Liang P; Soden PA; Zettervall SL; Shean KE; Deery SE; Guzman RJ; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2018 Aug; 68(2):487-494. PubMed ID: 29576404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial injury after endovascular revascularization in critical limb ischemia predicts 1-year mortality: a prospective observational cohort study.
    Szczeklik W; Krzanowski M; Maga P; Partyka Ł; Kościelniak J; Kaczmarczyk P; Maga M; Pieczka P; Suska A; Wachsmann A; Górka J; Biccard B; Devereaux PJ
    Clin Res Cardiol; 2018 Apr; 107(4):319-328. PubMed ID: 29177795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.
    Shammas AN; Jeon-Slaughter H; Tsai S; Khalili H; Ali M; Xu H; Rodriguez G; Cawich I; Armstrong EJ; Brilakis ES; Banerjee S
    J Endovasc Ther; 2017 Jun; 24(3):376-382. PubMed ID: 28440113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
    Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
    J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.
    Hussain MA; Al-Omran M; Mamdani M; Eisenberg N; Premji A; Saldanha L; Wang X; Verma S; Lindsay TF
    JAMA Surg; 2016 Aug; 151(8):742-50. PubMed ID: 27050566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.
    Subherwal S; Bhatt DL; Li S; Wang TY; Thomas L; Alexander KP; Patel MR; Ohman EM; Gibler WB; Peterson ED; Roe MT
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):541-9. PubMed ID: 22715460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of lower extremity peripheral artery disease in veterans.
    Willey J; Mentias A; Vaughan-Sarrazin M; McCoy K; Rosenthal G; Girotra S
    J Vasc Surg; 2018 Aug; 68(2):527-535.e5. PubMed ID: 29588132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.